General Information
Version
GHS 2.0
Revision date
2024-07-17
Product name
Lithium chloride for biochemistry
CAS No.
7447-41-8
Icons in SDS
Company Information
company name
NeoFroxx GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@neofroxx.com, info@neofroxx.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H319
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Classification according to GHS
Section
Hazard categories
Category Hazard class and cat- Hazard state- egory ment 3.1O 3.2 3.3 4 Acute Tox. 4 H302 acute toxicity (oral) 2 Skin Irrit. 2 H315 skin corrosion/irritation 2 Eye Irrit. 2 H319 eye damage/eye irritation For full text of abbreviations see SECTION 16.
Hazard pictograms
GHS07
Hazard statements
H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation.
Precautionary statements
P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protec- tion. P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. P302+P352 IF ON SKIN: Wash with plenty of water. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see on this label). P330 Rinse mouth. P332+P313 If skin irritation occurs: Get medical advice/attention. P337+P313 If eye irritation persists: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse. P501 Dispose of contents/container to industrial combustion plant.
Results of PBT and vPvB assessment
According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
